XTL Biopharmaceuticals Ltd. (XTLB)
XTLB trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$1.98
+3.12% on the day
Market cap
$4.9M
Nano cap
Revenue · 2024
$451K
No prior year to compare
Net income · 2024
-$1.0M
-227.7% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC 20-F (ifrs-full:Revenue), period ending 2024-12-31, https://www.sec.gov/Archives/edgar/data/1023549/000121390025037590/0001213900-25-037590-index.htm. Net income: SEC 20-F (ifrs-full:ProfitLoss), period ending 2024-12-31.
Profile
| Field | Value |
|---|---|
| Ticker | XTLB on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | Israel |
| IPO year | Not reported by the screener |
| SEC CIK | 0001023549 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | L3 |
Financials · 2024
| Line | Value |
|---|---|
| Revenue | $451K |
| Net income | -$1.0M |
| Operating income | Not in SEC XBRL data |
| Net margin | -227.7% |
| Operating margin | Operating income not reported |
| Revenue growth | No prior-year revenue to compare |
| Cash | Not in SEC XBRL data |
| Total assets | Not in SEC XBRL data |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 10.8× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document PROSPECTUS SUPPLEMENT | 424B3 | 2021-06-09 |
| Latest annual report ANNUAL REPORT | 20-F | 2026-06-30 |
| Latest quarterly / interim REPORT OF FOREIGN PRIVATE ISSUER | 6-K | 2026-10-14 |
Source: SEC EDGAR submissions feed, 546 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| XBIO | Xenetic Biosciences Inc. | $2.10 | -0.94% | $4.9M |
| PCSA | Processa Pharmaceuticals Inc. | $1.77 | -6.84% | $5.0M |
| KALA | KALA BIO Inc. | $0.2600 | -7.14% | $5.0M |
| PULM | Pulmatrix Inc. | $1.38 | -3.50% | $5.0M |
| LNAI | Lunai Bioworks Inc. | $1.03 | -7.21% | $4.7M |
| ADXN | Addex Therapeutics Ltd | $3.01 | -0.99% | $5.1M |
| GELS | Gelteq Limited | $0.4801 | -2.06% | $5.1M |
| SCNX | Scienture Holdings Inc. | $3.24 | -17.14% | $5.3M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier